(LLY) Eli Lilly Expands European Business In Animal Health Products

March 9th, 2010

Eli Lilly (LLY), through its animal health division, Elanco, has recently acquired the European rights to some of Pfizer’s (PFE) animal health products, consisting of vaccines, parasiticides and feed additives for both companion and production animals. In addition, Lilly will acquire a manufacturing facility in Ireland that is currently used in the production of animal vaccines. The financial details of the deal are not known.

The acquired products used to be marketed by Pfizer and Wyeth’s Fort Dodge operations. Pfizer had to divest these products following a directive from the European Commission following its acquisition of Wyeth last year. Pfizer and Lilly have signed a manufacturing supply agreement to ensure an uninterrupted supply of product to the customers.

Companion animals include dogs, cats, other pets and horses, while production animals include cattle and other food-producing animals. We believe this is a large market with an attractive growth profile in the companion animal segment as increased spending is driven by the rising number of households with pets, enhanced human-animal bonding, aging pet population, more focus on animal health or preventative care, advancements in pharmaceuticals and diagnostic testing, and extensive marketing programs sponsored by companion animal nutrition and pharmaceutical companies.

The potential of the production animal segment is primarily based on disease prevention, improved productivity as well as a growing focus on food safety.

Eli Lilly is keen on improving its top line as some of its key products are slated to lose patent exclusivity in the next few years. In order to achieve this, the company has entered into several deals in the past few months.

Zacks Investment Research

More on this topic (What's this?)
Prepare for Europe – "It's Going to Be Ugly" (Money Morning, 1/16/12)
Davos: Europe Holds Back Recovery (Wall Street Daily, 1/26/12)
Sold Eli Lilly & Co (LLY) Naked Puts (My Trader's Journal, 3/30/10)
The Shale Boom is Giving Birth to Other Bull Markets (Wealth Daily, 1/17/12)
Read more on Eli Lilly and Company, European Union, Pfizer at Wikinvest

Related Posts:

  1. (LLY) Eli Lilly Misses Earnings Reports by a PennyThis morning, Eli Lilly (LLY) reported fourth quarter and fiscal 2009 results. The company reported...
  2. (PFE) Pfizer’s Revatio Drug Earns European Commission ApprovalRecently, Pfizer (PFE) received European Commission approval for Revatio (sildenafil) in injectable form for patients...
  3. (LLY) Eli Lilly Gets Good News From the US Food and Drug AdministrationRecently, Eli Lilly (LLY) received US Food and Drug Administration (FDA) approval for Zyprexa Relprevv...
  4. (PFE) Pfizer Expands Chinese Market PresencePfizer (PFE) is looking to increase its presence in one of the most sought-after emerging...
  5. (BMY) Bristol-Myers Squibb Seeks European Approval for ApixabanBristol-Myers Squibb Co. (BMY) and Pfizer (PFE) recently announced that they intend to seek European...
  6. (LLY) Eli Lilly Beats Estimates and Raises GuidanceThis morning, Eli Lilly & Co. (LLY) reported strong third quarter financials. The company’s earnings...


Search Posts by Tag: | | | | Drug Manufacturers - Major | Healthcare

RSS Feeds by Tag: Eli Lilly & Company | LLY | PFE | Pfizer Inc. | Drug Manufacturers - Major | Healthcare |

Other Posts by: | RSS Feed for this author